| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/04/2002 | CA2423487A1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/04/2002 | CA2423464A1 Hydroxy acid integrin antagonists |
| 04/04/2002 | CA2423434A1 Lactone integrin antagonists |
| 04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | CA2423251A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | CA2422916A1 Compounds and methods for use thereof in the treatment of cancer or viral infections |
| 04/04/2002 | CA2420475A1 Ige receptor antagonists |
| 04/04/2002 | CA2418260A1 Erythromycin derivative and medicament comprising the same |
| 04/03/2002 | EP1193270A2 Pyrrolobenzodiazepines |
| 04/03/2002 | EP1193269A1 Crystalline 1-methylcarbapenem compounds |
| 04/03/2002 | EP1193267A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases |
| 04/03/2002 | EP1193266A1 Quinolinecarboxylic acid derivative or salts thereof |
| 04/03/2002 | EP1193261A1 New thiadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/03/2002 | EP1192265A1 Anti-viral vectors |
| 04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192249A1 47 human secreted proteins |
| 04/03/2002 | EP1192247A1 Sphingosine kinase enzyme |
| 04/03/2002 | EP1192242A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 04/03/2002 | EP1192171A1 48 human secreted proteins |
| 04/03/2002 | EP1192152A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
| 04/03/2002 | EP1192148A1 Thiochroman derivatives resisting neurological disorders |
| 04/03/2002 | EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity |
| 04/03/2002 | EP1192128A1 Thiol derivative, metallo-beta-lactamase inhibitors |
| 04/03/2002 | EP1192127A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
| 04/03/2002 | EP1191975A2 Improvement of t cell mediated immunity |
| 04/03/2002 | EP1191948A2 High dose radionuclide complexes for bone marrow suppression |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | EP1191939A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
| 04/03/2002 | EP1191938A2 Immunity generation |
| 04/03/2002 | EP1191934A1 Il-8 receptor antagonists |
| 04/03/2002 | EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 04/03/2002 | EP1191924A1 Pharmaceutical dosage form for pulsatile delivery of (d-threo)-methylphenidate and a second cns stimulant |
| 04/03/2002 | EP1191843A2 Antibacterial compositions |
| 04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1133319A4 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/03/2002 | EP1043974B1 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus |
| 04/03/2002 | EP1042001B1 Use of microparticles combined with submicron oil-in-water emulsions |
| 04/03/2002 | EP0999838B1 Self-emulsifying formulation for lipophilic compounds |
| 04/03/2002 | EP0946580B1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 04/03/2002 | EP0856051B1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 04/03/2002 | EP0833661B1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 04/03/2002 | EP0754049B1 Anti-fungal methods and materials |
| 04/03/2002 | EP0726941B1 Methods for (ex vivo) therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 04/03/2002 | CN1343257A Recombined procine adenovirus based viral vaccines and vectors |
| 04/03/2002 | CN1343216A Erythromycin derivatives |
| 04/03/2002 | CN1343215A 6-O-substituted macrolides having antibacterial activity |
| 04/03/2002 | CN1343209A Camptothecin derivatives having antitumor activity |
| 04/03/2002 | CN1343206A Cyclocompound |
| 04/03/2002 | CN1343205A Dimeric compounds and as inhibitors of neuraminidase |
| 04/03/2002 | CN1343174A 计量阀 Metering valve |
| 04/03/2002 | CN1343128A Medicinal compositions |
| 04/03/2002 | CN1343124A Bacterial membrane fractions with adjuvant effect |
| 04/03/2002 | CN1342771A Expression purification of tubercle mycobacterium Ag85B antigen and its application in vaccine |
| 04/03/2002 | CN1342753A Hepatitis C virus and its external cell culture method |
| 04/03/2002 | CN1342651A Ganciclovir sodium hydrate and its preparing process and application |
| 04/03/2002 | CN1342486A Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing |
| 04/03/2002 | CN1342481A Medicine for treating AIDS |
| 04/03/2002 | CN1342465A 'Xuanfeizhiyang' powder for treating lung disease |
| 04/03/2002 | CN1342464A Antivirus antioxidizing active extract of proplis and its molecular inclusion compound |
| 04/03/2002 | CN1082050C Azole cojpounds endowed with antimycotic activity for human and veterinary use |
| 04/03/2002 | CN1081919C Preparation for skin and mucous membrane |
| 04/02/2002 | USRE37623 Enzyme inhibitors, their synthesis, and methods for use |
| 04/02/2002 | US6365787 Compounds for the suppression of HIV TAT transactivation |
| 04/02/2002 | US6365768 Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulators |
| 04/02/2002 | US6365751 Antibiotic oxazolidinone derivatives |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 04/02/2002 | US6365664 Gels formed by the interaction of poly(aldehyde) with various substances |
| 04/02/2002 | US6365625 Narrow or mono-dispersed naphthalenesulfonic acid formaldehyde condensation polymers of a molecular weight minimizing anticoagulation; antigens |
| 04/02/2002 | US6365612 Benzosultam oxazolidinone antibacterial agents |
| 04/02/2002 | US6365598 Pyrroloquinolines for treatment of obesity |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | US6365575 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 04/02/2002 | US6365574 Gradual crystallization of azithromycin from ethanol by the addition of a minimal amount of water; hydrophobic |
| 04/02/2002 | US6365394 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/02/2002 | US6365389 Human protein kinase H2LAU20 |
| 04/02/2002 | US6365351 Non-invasive method for detecting target RNA |
| 04/02/2002 | US6365343 Treating rhinovirus infection by using insufflate for nasal administration composed of soluble interacellular adhesion molecule, type i; a bulking agent; and carboxymethyl cellulose, sodium salt |
| 04/02/2002 | US6365184 Multiple unit tableted dosage forms containing acid susceptible proton pump inhibitor in combination with one or more nsaids and wherein at least proton pump inhibitor is protected by enteric coated layer |
| 04/02/2002 | US6365160 Polyprotein construct comprising amino acid sequences fused directly or indirectly together, each being sequence of early open reading frame protein of papillomavirus, or immunogenic variant or non-full length deletion mutant thereof |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | US6365158 Immunizing avian host with purified recombinant fusion protein comprising non-toxin protein sequence and portion of clostridium difficile toxin b sequence so as to generate neutralizing antitoxin |
| 04/02/2002 | US6365156 Contacting mucosal membrane of animal with chimeric molecule comprising viral-specific ligand and bacterial-specific ligand which is specific for bacteria colonizing membrane |
| 04/02/2002 | CA2357925A1 Prophylactic use of n-methyl-d-asparate (nmda) antagonists |
| 04/02/2002 | CA2039909C Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates |
| 04/02/2002 | CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024897A2 Conditionally replicating viral vectors and their use |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024887A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | WO2002024754A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 03/28/2002 | WO2002024746A1 Transfer factor from birds eggs |
| 03/28/2002 | WO2002024735A2 Peptide inhibitors of hiv entry |
| 03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | WO2002024717A1 Antisense modulation of flip-c expression |
| 03/28/2002 | WO2002024711A1 Novel thiazole bicyclic compounds |
| 03/28/2002 | WO2002024708A1 Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic |
| 03/28/2002 | WO2002024706A2 Water soluble rapamycin esters |
| 03/28/2002 | WO2002024694A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics |